Neuroendocrine differentiation (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Neuroendocrine differentiation" in English language version.

refsWebsite

Global rank English rank

11nih.gov

4^th place

8doi.org

2^nd place

3semanticscholar.org

11^th place

8^th place

doi.org

di Sant'Agnese PA (July 1992). "Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications". Cancer. 70 (1 Suppl): 254–68. doi:10.1002/1097-0142(19920701)70:1+<254::aid-cncr2820701312>3.0.co;2-e. PMID 1350941.
Abrahamsson PA (1996). "Neuroendocrine differentiation and hormone-refractory prostate cancer". The Prostate. Supplement. 6 (S6): 3–8. doi:10.1002/(SICI)1097-0045(1996)6+<3::AID-PROS2>3.0.CO;2-T. PMID 8630226. S2CID 8846395.
Vashchenko N, Abrahamsson PA (February 2005). "Neuroendocrine differentiation in prostate cancer: implications for new treatment modalities". European Urology. 47 (2): 147–55. doi:10.1016/j.eururo.2004.09.007. PMID 15661408.
Jongsma J, Oomen MH, Noordzij MA, et al. (February 1999). "Kinetics of neuroendocrine differentiation in an androgen-dependent human prostate xenograft model". The American Journal of Pathology. 154 (2): 543–51. doi:10.1016/S0002-9440(10)65300-X. PMC 1850014. PMID 10027412.
Ishida E, Nakamura M, Shimada K, Tasaki M, Konishi N (2009). "Immunohistochemical analysis of neuroendocrine differentiation in prostate cancer". Pathobiology. 76 (1): 30–8. doi:10.1159/000178153. PMID 19188748.
Huang J, Yao JL, di Sant'Agnese PA, Yang Q, Bourne PA, Na Y (September 2006). "Immunohistochemical characterization of neuroendocrine cells in prostate cancer". The Prostate. 66 (13): 1399–406. doi:10.1002/pros.20434. PMID 16865726. S2CID 43634696.
Bonkhoff H (2001). "Neuroendocrine differentiation in human prostate cancer. Morphogenesis, proliferation and androgen receptor status". Annals of Oncology. 12 Suppl 2: S141–4. doi:10.1093/annonc/12.suppl_2.s141. PMID 11762342.
Yao JL, Madeb R, Bourne P, et al. (June 2006). "Small cell carcinoma of the prostate: an immunohistochemical study". The American Journal of Surgical Pathology. 30 (6): 705–12. doi:10.1097/00000478-200606000-00005. PMID 16723847. S2CID 19086188.

nih.gov

pubmed.ncbi.nlm.nih.gov

di Sant'Agnese PA (July 1992). "Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications". Cancer. 70 (1 Suppl): 254–68. doi:10.1002/1097-0142(19920701)70:1+<254::aid-cncr2820701312>3.0.co;2-e. PMID 1350941.
Abrahamsson PA (1996). "Neuroendocrine differentiation and hormone-refractory prostate cancer". The Prostate. Supplement. 6 (S6): 3–8. doi:10.1002/(SICI)1097-0045(1996)6+<3::AID-PROS2>3.0.CO;2-T. PMID 8630226. S2CID 8846395.
Sun Y, Niu J, Huang J (2009). "Neuroendocrine differentiation in prostate cancer". American Journal of Translational Research. 1 (2): 148–62. PMC 2776313. PMID 19956427.
Vashchenko N, Abrahamsson PA (February 2005). "Neuroendocrine differentiation in prostate cancer: implications for new treatment modalities". European Urology. 47 (2): 147–55. doi:10.1016/j.eururo.2004.09.007. PMID 15661408.
Jongsma J, Oomen MH, Noordzij MA, et al. (February 1999). "Kinetics of neuroendocrine differentiation in an androgen-dependent human prostate xenograft model". The American Journal of Pathology. 154 (2): 543–51. doi:10.1016/S0002-9440(10)65300-X. PMC 1850014. PMID 10027412.
Ishida E, Nakamura M, Shimada K, Tasaki M, Konishi N (2009). "Immunohistochemical analysis of neuroendocrine differentiation in prostate cancer". Pathobiology. 76 (1): 30–8. doi:10.1159/000178153. PMID 19188748.
Huang J, Yao JL, di Sant'Agnese PA, Yang Q, Bourne PA, Na Y (September 2006). "Immunohistochemical characterization of neuroendocrine cells in prostate cancer". The Prostate. 66 (13): 1399–406. doi:10.1002/pros.20434. PMID 16865726. S2CID 43634696.
Bonkhoff H (2001). "Neuroendocrine differentiation in human prostate cancer. Morphogenesis, proliferation and androgen receptor status". Annals of Oncology. 12 Suppl 2: S141–4. doi:10.1093/annonc/12.suppl_2.s141. PMID 11762342.
Yao JL, Madeb R, Bourne P, et al. (June 2006). "Small cell carcinoma of the prostate: an immunohistochemical study". The American Journal of Surgical Pathology. 30 (6): 705–12. doi:10.1097/00000478-200606000-00005. PMID 16723847. S2CID 19086188.

ncbi.nlm.nih.gov

Sun Y, Niu J, Huang J (2009). "Neuroendocrine differentiation in prostate cancer". American Journal of Translational Research. 1 (2): 148–62. PMC 2776313. PMID 19956427.
Jongsma J, Oomen MH, Noordzij MA, et al. (February 1999). "Kinetics of neuroendocrine differentiation in an androgen-dependent human prostate xenograft model". The American Journal of Pathology. 154 (2): 543–51. doi:10.1016/S0002-9440(10)65300-X. PMC 1850014. PMID 10027412.

semanticscholar.org

api.semanticscholar.org

Abrahamsson PA (1996). "Neuroendocrine differentiation and hormone-refractory prostate cancer". The Prostate. Supplement. 6 (S6): 3–8. doi:10.1002/(SICI)1097-0045(1996)6+<3::AID-PROS2>3.0.CO;2-T. PMID 8630226. S2CID 8846395.
Huang J, Yao JL, di Sant'Agnese PA, Yang Q, Bourne PA, Na Y (September 2006). "Immunohistochemical characterization of neuroendocrine cells in prostate cancer". The Prostate. 66 (13): 1399–406. doi:10.1002/pros.20434. PMID 16865726. S2CID 43634696.
Yao JL, Madeb R, Bourne P, et al. (June 2006). "Small cell carcinoma of the prostate: an immunohistochemical study". The American Journal of Surgical Pathology. 30 (6): 705–12. doi:10.1097/00000478-200606000-00005. PMID 16723847. S2CID 19086188.